Kumar, Ravindra,Alimzhanov, Marat,Pearsall, Robert Scott
申请号：
AU2017222526
公开号：
AU2017222526A1
申请日:
2017.02.22
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
Disclosed herein are ActRII antagonists and methods for increasing immune responses and/or activity in patients in need thereof including, for example, cancer patients. In some embodiments, the disclosure relates to methods for treating cancer and/or tumors in a patient comprising administration of an ActRII antagonists and a PDl-PDLl antagonist.
